Preprint Article Version 1 This version is not peer-reviewed

Antibacterial and Biofilm Modulating Potential of Ferulic Acid Grafted Chitosan against Human Pathogenic Bacteria

Version 1 : Received: 29 June 2018 / Approved: 29 June 2018 / Online: 29 June 2018 (15:21:41 CEST)

A peer-reviewed article of this Preprint also exists.

Dasagrandhi, C.; Park, S.; Jung, W.-K.; Kim, Y.-M. Antibacterial and Biofilm Modulating Potential of Ferulic Acid-Grafted Chitosan against Human Pathogenic Bacteria. Int. J. Mol. Sci. 2018, 19, 2157. Dasagrandhi, C.; Park, S.; Jung, W.-K.; Kim, Y.-M. Antibacterial and Biofilm Modulating Potential of Ferulic Acid-Grafted Chitosan against Human Pathogenic Bacteria. Int. J. Mol. Sci. 2018, 19, 2157.

Journal reference: Int. J. Mol. Sci. 2018, 19, 2157
DOI: 10.3390/ijms19082157

Abstract

Emergence of more virulent forms of human pathogenic bacteria with multi drug resistance is a serious global issue and requires alternative control strategies. The current study was focused to investigate the antibacterial and antibiofilm potential of ferulic acid grafted chitosan (CFA) against Listeria monocytogenes (LM), Pseudomonas aeruginosa (PA), and Staphylococcus aureus (SA). The present result showed that CFA at 64 µg/mL concentration exhibit bactericidal action against LM and SA (>4 log reduction) and bacteriostatic action against PA (<2 log CFU) within 24 h of incubation. Further studies based on propidium iodide uptake assay, measurement of material released from the cell, and electron microscopic analysis revealed that the bactericidal action of CFA was due to the altered membrane integrity and permeability. CFA dose-dependently inhibited biofilm formation (52-89% range), its metabolic activity (30.8-75.1% range) and eradicated mature biofilms, and reduced viability (71-82% range) of the test bacteria. Also, the swarming motility of LM was differentially affected at sub-MIC concentration of CFA. In the present study, the ability of CFA to kill and alter the virulence production in human pathogenic bacteria will insight a new scope for the application of these biomaterials in healthcare to effectively treat bacterial infections.

Subject Areas

antibacterial agent; antibiofilm; ferulic acid grafted chitosan; human pathogenic bacteria

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.